Rune Labs Unveils $12 Million Strategic Round to Accelerate Adoption of Novel Parkinson's ...

Retrieved on: 2024-02-06 20:07:13

Tags for this article:

Clinical pharmacology

Clinical research

Clinical trial

Design of experiments

Food and Drug Administration

Rune Labs

Click the tags to see associated articles and topics

Rune Labs Unveils $12 Million Strategic Round to Accelerate Adoption of Novel Parkinson's .... View article details on HISWAI: https://www.healthcareittoday.com/2024/02/06/rune-labs-unveils-12-million-strategic-round-to-accelerate-adoption-of-novel-parkinsons-technologies/

Summary

Article Summary: Rune Labs, a biopharma company specializing in precision neurology, raised $12 million, furthering its total funding to over $42 million. The company's StrivePD software, FDA-cleared for Parkinson's symptom data collection, leverages AI to advance clinical research and improve patient care, aligning with the tags: Clinical pharmacology, Clinical research, Clinical trial, Design of experiments, Food and Drug Administration, and Rune Labs.

Article found on: www.healthcareittoday.com

View Original Article